Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality. Issue 1 (15th March 2020)

Record Type:: Journal Article
Title:: Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality. Issue 1 (15th March 2020)
Main Title:: Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality
Authors:: Niavarani, Seyedeh-Raheleh
Lawson, Christine
Boudaud, Marie
Simard, Camille
Tai, Lee-Hwa
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 8:Issue 1(2020)
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8:Issue 1(2020)
Issue Display:: Volume 8, Issue 1 (2020)
Year:: 2020
Volume:: 8
Issue:: 1
Issue Sort Value:: 2020-0008-0001-0000
Page Start:
Page End:
Publication Date:: 2020-03-15
Subjects:: immunogenicity, vaccine -- oncolytic virotherapy -- breast neoplasms -- tumor microenvironment
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1136/jitc-2019-000465 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 25456.xml